STOCK TITAN
  1. Home
  2. Sec-filings
  3. EHC
  4. [Form 4] Encompass Health Corp Insider Trading Activity

Encompass Health (EHC) director awarded 1,634-share stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

O'Connor Kevin J. reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Kevin J. O'Connor received a grant of 1,634 shares of Encompass Health Common Stock. The shares were awarded at no cash cost as part of his annual restricted stock unit grant under the Corporation's 2025 Omnibus Performance Incentive Plan. Following this equity award, O'Connor directly holds 11,563 shares of Encompass Health Common Stock, reflecting a routine compensation-related increase in his ownership stake.

Positive

  • None.

Negative

  • None.
Insider O'Connor Kevin J.
Role null
Type Security Shares Price Value
Grant/Award Encompass Health Common Stock 1,634 $0.00 --
Holdings After Transaction: Encompass Health Common Stock — 11,563 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Stock grant size 1,634 shares Annual restricted stock unit grant to director on 2026-05-07
Holdings after transaction 11,563 shares Total Encompass Health Common Stock directly owned after grant
Grant price per share $0.0000 per share Reported transaction price for the granted shares
restricted stock units financial
"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2025 Omnibus Performance Incentive Plan financial
"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."
non-derivative financial
"transaction_type": "non-derivative""
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
O'Connor Kevin J.
(Last)(First)(Middle)
9001 LIBERTY PARKWAY
(Street)
BIRMINGHAM ALABAMA 35242
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Encompass Health Common Stock05/07/2026A1,634(1)A$011,563D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.
/s/ Patrick Darby, attorney-in-fact for Kevin J. O'Connor05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Encompass Health (EHC) director Kevin O'Connor report in this Form 4?

Kevin J. O'Connor reported receiving 1,634 shares of Encompass Health Common Stock. The award was an annual restricted stock unit grant under the 2025 Omnibus Performance Incentive Plan, increasing his direct holdings to 11,563 shares.

Was Kevin O'Connor’s Encompass Health stock transaction a purchase or a grant?

The transaction was a grant, not an open-market purchase. O'Connor acquired 1,634 shares as a compensation-related award with a reported price per share of $0.0000, reflecting no cash paid for the shares.

How many Encompass Health shares does Kevin O'Connor own after this award?

After the grant, Kevin O'Connor directly owns 11,563 shares of Encompass Health Common Stock. This total includes the newly awarded 1,634 shares reported in the Form 4 insider filing for the non-derivative equity transaction.

What plan governed Kevin O'Connor’s Encompass Health stock grant?

The equity award was made under Encompass Health’s 2025 Omnibus Performance Incentive Plan. Footnote disclosure states it was an annual grant of restricted stock units issued as part of the company’s long-term incentive compensation program.

Does this Encompass Health Form 4 show any stock sales by Kevin O'Connor?

No stock sales are reported in this Form 4. The filing shows only one acquisition transaction, a grant of 1,634 shares of Encompass Health Common Stock, with no dispositions or derivative exercises disclosed in the summarized data.